25 results on '"Maron, Martin S."'
Search Results
2. CMR phenotyping of asymptomatic hypertrophic cardiomyopathy at increased risk for heart failure progression
3. Late Gadolinium Enhancement Predicts Sudden Death Risk over Long-term Follow-up in Patients with Hypertrophic Cardiomyopathy
4. CMR 2-42 - Late Gadolinium Enhancement Predicts Sudden Death Risk over Long-term Follow-up in Patients with Hypertrophic Cardiomyopathy
5. Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
6. Is the 12-lead electrocardiogram of value in the prognostic assessment of patients with hypertrophic cardiomyopathy?
7. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy
8. Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
9. Characterization of tissue heterogeneity by contrast-enhanced cardiovascular magnetic resonance imaging is a powerful predictor of ventricular tachyarrhythmias on ambulatory holter ECG in hypertrophic cardiomyopathy
10. 233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy
11. 2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
12. 2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
13. 2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
14. 2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
15. 2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
16. Is the 12-lead electrocardiogram of value in the prognostic assessment of patients with hypertrophic cardiomyopathy?
17. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy
18. Characterization of tissue heterogeneity by contrast-enhanced cardiovascular magnetic resonance imaging is a powerful predictor of ventricular tachyarrhythmias on ambulatory holter ECG in hypertrophic cardiomyopathy
19. Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
20. 2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
21. 2075 Papillary muscles and trabeculations significantly impact ventricular volume, ejection fraction, and regurgitation assessment by cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
22. 2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
23. 2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
24. 233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy
25. 2027 Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance thresholding techniques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.